Blankinship & Foster »

Summit Therapeutics shares owned by Blankinship & Foster

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Blankinship & Foster from 13F filings

Historical chart of Blankinship & Foster investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Blankinship & Foster consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Blankinship & Foster

Quarter filed Position value Share count Share price at filing
2025-09-30 $264k 13k 20.66
2025-06-30 $272k 13k 21.28
2025-03-31 $247k 13k 19.29
2024-12-31 $228k 13k 17.85
2024-09-30 $280k 13k 21.90
2024-06-30 $100k 13k 7.80
2024-03-31 $53k 13k 4.14
2023-12-31 $33k 13k 2.61
2023-09-30 $24k 13k 1.87
2023-06-30 $32k 13k 2.51